06torrentlogo1
Darifenacin Tablet, Extended Release
Product Images NDC 13668-202
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Darifenacin (NDC 13668-202). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Torrent Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
07torrentlogo2
15 mg 30 Ct Bottle Label
This is a description of a medication called Darifenacin. Each tablet contains 17.860 mg of darifenacin hydrobromide (equivalent to 15 mg darfenacin) and should be stored at 20-25°C. The tablets should be swallowed whole and dispensed in a child-resistant container. The dosage should be determined by the prescribing information. The medication is manufactured by Torrent Pharmaceuticals LTD in India and should only be sold with a prescription.*
75 mg 30 Ct Bottle Label
This is a description of a medication called Darifenacin. It is available in extended-release tablets of 30 tablets with the strength of 83500 conrs and a product code of NG 13668-202-30. However, the remaining text seems to be jumbled and does not make sense, so further information cannot be inferred.*
Figure 2a Study 1
Figure 2b, Study 2
Figure 2c, Study 3
Figure 1
Structure
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
